Who owns LLY
4,198 institutions reported holding LLY for 2026Q1, together 86% of the company, fewer than the 4,316 a quarter earlier.
4,198
Institutions reporting a position · as of 2026Q1 · down from 4,316 the quarter before
- Shares held by institutions
- 774.1M
Shares held by institutions · 86% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $711.2B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 37%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 52
- New positions
- 218
- Positions exited
- 340
- Added to
- 1,649
- Reduced
- 1,447
- Top 10 holdersof the company
- 48%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 4,198 | 774.1M | $711.2B |
| 2025Q4 | 4,316 | 788.8M | $845.1B |
| 2025Q3 | 3,808 | 762.8M | $581.7B |
| 2025Q2 | 3,813 | 781.0M | $608.2B |
| 2025Q1 | 3,843 | 833.1M | $686.6B |
| 2024Q4 | 3,832 | 779.6M | $601.4B |
| 2024Q3 | 3,598 | 786.7M | $684.1B |
| 2024Q2 | 3,511 | 777.8M | $703.7B |
| 2024Q1 | 3,399 | 779.6M | $605.1B |
| 2023Q4 | 3,215 | 782.0M | $455.6B |
| 2023Q3 | 2,924 | 783.1M | $420.5B |
| 2023Q2 | 2,768 | 781.6M | $365.4B |
| 2023Q1 | 2,579 | 838.4M | $269.0B |
| 2022Q4 | 2,633 | 788.1M | $288.1B |
| 2022Q3 | 2,451 | 789.6M | $256.3B |
| 2022Q2 | 2,412 | 786.8M | $255.0B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| LILLY ENDOWMENT INC | 91.9M | 10% | $84.5B |
| VANGUARD GROUP INC | 82.6M | 9.2% | $76.0B |
| BlackRock Inc. | 66.4M | 7.4% | $61.1B |
| PNC FINANCIAL SERVICES GROUP, INC. | 51.3M | 5.7% | $47.2B |
| STATE STREET CORP | 35.6M | 4.0% | $32.8B |
| FMR LLC | 26.3M | 2.9% | $24.2B |
| Capital Research Global Investors | 24.6M | 2.7% | $22.7B |
| GEODE CAPITAL MANAGEMENT LLC | 20.2M | 2.3% | $18.5B |
| Capital World Investors | 15.6M | 1.7% | $14.4B |
| MORGAN STANLEY | 15.4M | 1.7% | $14.2B |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Drug Manufacturers - General
Ranks #1 of 16 by Smart Score